Applied DNA Sciences (NASDAQ:APDN) Announces Quarterly Earnings Results

Applied DNA Sciences (NASDAQ:APDN) announced its quarterly earnings results on Thursday. The technology company reported ($0.56) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.24), Zacks reports. Applied DNA Sciences had a negative net margin of 203.76% and a negative return on equity of 111.18%.

Applied DNA Sciences Stock Down 2.4 %

Shares of NASDAQ:APDN opened at $0.17 on Friday. The company’s fifty day moving average is $0.19 and its 200 day moving average is $0.52. Applied DNA Sciences has a 52 week low of $0.12 and a 52 week high of $14.40. The stock has a market cap of $9.39 million, a PE ratio of -0.02 and a beta of 0.37.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.